Deluccia Robert J - Jun 24, 2021 Form 3 Insider Report for Acurx Pharmaceuticals, Inc. (ACXP)

Role
Director, 10%+ Owner
Signature
/s/ Robert J. DeLuccia
Stock symbol
ACXP
Transactions as of
Jun 24, 2021
Transactions value $
$0
Form type
3
Date filed
6/24/2021, 06:22 PM
Next filing
Jul 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ACXP Common Stock 1.03M Jun 24, 2021 Direct F1
holding ACXP Common Stock 3.85K Jun 24, 2021 By spouse F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 6.25K $2.00 Direct F1
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 8.33K $3.00 Direct F1
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 3.13K $4.00 Direct F1
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 3.13K $4.00 Direct F1
holding ACXP Warrants for Common Stock Jun 24, 2021 Common Stock 3.13K $4.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the conversion of membership interests to common stock pursuant to the corporate conversion of Acurx Pharmaceuticals, Inc.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney